Related Experiment Video
Updated: Oct 2, 2025

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation
Published on: March 2, 2016
Epigenetic regulation of inflammation by microRNAs in post-infectious bronchiolitis obliterans
Ruth P Duecker1, Ines De Mir Messa2, Silvija-Pera Jerkic1
1Division for Allergy, Pneumology and Cystic Fibrosis Department for Children and Adolescence Goethe University Frankfurt Germany.
Objectives:
Post-infectious bronchiolitis obliterans (PiBO) is a rare, chronic disease initiated by severe infection and followed by perpetuating inflammation and obliteration of the small airways. MicroRNAs (miRNAs) have been proposed to play a central role as epigenetic regulators, which control resolution and prevent the uncontrolled progress of inflammation. The aim of this study was to define biomarkers on the level of post-transcriptional gene regulation in order to characterise PiBO.
Methods:
A total of 39 patients with well-defined PiBO and 31 controls from two centres, Barcelona, Spain, and Frankfurt, Germany, were analysed by next-generation sequencing (NGS). The evaluation of the biological targets of the miRNAs was performed by pathway enrichment analysis and protein-protein interaction network analysis respectively.
Results:
Patients with PiBO had significantly lower lung function values and increased airway inflammation in induced sputum as indicated by total cell counts, neutrophils, IL-1β, IL-6, IL-8 and TGF-β compared to controls.Next-generation sequencing analysis revealed a total of 22 dysregulated miRNAs, which passed significance threshold for Padj ≤ 0.001 with 17 being upregulated and 5 being downregulated. Of these dysregulated miRNAs, miR-335-5p, miR-186-5p, miR-30b-5p and miR-30c-5p were further validated using qRT-PCR. Interestingly, these miRNAs are functionally implicated in cytokine-cytokine receptor interaction, TGF-β signalling and FoxO signalling pathway and significantly correlated with lung function values (FEV1).
Conclusion:
Our results demonstrate an aberrant miRNA expression profile in PiBO, which impacts pathways responsible for the regulation of inflammation and fibrosis. The defined miRNAs are useful biomarkers and should be assessed as potential target in the field of miRNA therapeutics.
Insights
Post-infectious bronchiolitis obliterans (PiBO) involves airway inflammation. This study identified specific microRNAs (miRNAs) linked to PiBO, suggesting their potential as diagnostic biomarkers and therapeutic targets.
Area of Science:
- Pulmonary Medicine
- Epigenetics
- Molecular Biology
Background:
- Post-infectious bronchiolitis obliterans (PiBO) is a rare, chronic airway disease following severe infection.
- MicroRNAs (miRNAs) are epigenetic regulators implicated in controlling inflammation and disease progression.
Purpose of the Study:
- To identify biomarkers at the post-transcriptional gene regulation level for characterizing PiBO.
- To investigate the role of miRNAs in the pathogenesis of PiBO.
Main Methods:
- Next-generation sequencing (NGS) was used to analyze miRNA expression in 39 PiBO patients and 31 controls.
- Pathway enrichment and protein-protein interaction network analyses were performed to evaluate miRNA targets.
- Quantitative reverse transcription PCR (qRT-PCR) validated specific miRNA dysregulations.
Main Results:
- PiBO patients exhibited reduced lung function and increased airway inflammation markers (neutrophils, IL-1β, IL-6, IL-8, TGF-β).
- NGS identified 22 significantly dysregulated miRNAs (17 upregulated, 5 downregulated) in PiBO patients.
- Four miRNAs (miR-335-5p, miR-186-5p, miR-30b-5p, miR-30c-5p) correlated with lung function (FEV1) and were involved in key signaling pathways.
Conclusions:
- Aberrant miRNA expression profiles are characteristic of PiBO, affecting inflammation and fibrosis pathways.
- The identified miRNAs serve as potential biomarkers for PiBO diagnosis.
- These miRNAs represent promising targets for future miRNA-based therapeutics in PiBO.
More Related Videos
08:16An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
Published on: July 7, 2017
12:27The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
Published on: April 2, 2014
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
MicroRNAs